Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 November 2021

The Council of the University of the Free State (UFS) carefully considered and approved a vaccination policy for the institution during its meeting on 26 November 2021. 

The aim of the COVID-19 Regulations and Required Vaccination Policy is to regulate access of staff, ad hoc contract workers, and students to all the university’s premises. The policy will be implemented as from 14 February 2022.

“The policy implies that the university does not force anyone to be vaccinated, but the institution has the right to require vaccination if you want to access the institution’s premises in order to protect our staff and students,” said Prof Francis Petersen, UFS Rector and Vice-Chancellor.    

Fiduciary duty to ensure safe and caring environment

“The UFS is a residential university that requires face-to-face engagement by both staff and students, and operational requirements entail that our staff, ad hoc contract workers, and students are regularly exposed to large groups on the three campuses. We have a fiduciary duty to ensure a safe and caring environment and to meet the health and safety obligations on the campuses,” said Prof Petersen. 

Since March 2020 and within the national lockdown levels, the institution has followed a predominantly online emergency-remote learning-and-teaching programme with a minimalistic approach to the return of staff and students to campus. Where possible and within the national lockdown levels, staff members have been working from home, except essential service employees and academic staff that were required to support students studying on campus in carefully managed face-to-face classes/interactions.  

“The viability of consistent remote working and study conditions is not in line with the culture and strategy of the UFS. Although a blended learning approach is supported, sole online learning will be detrimental to the quality of our graduates and the experience that the institution should offer to its students as a residential university,” said Prof Petersen.

Encouraging university community to vaccinate

The institution is greatly concerned about the number of staff, students, and ad hoc contract workers who have tested positive for COVID-19 since the commencement of the national lockdown. The pandemic has resulted in numerous individuals being placed in quarantine, testing positive or being incapacitated due to COVID-19 complications and deaths. “We believe that the policy will be a contributing factor in encouraging the entire university community to make the responsible decision to vaccinate,” said Prof Petersen.

Although the policy does not force anyone to vaccinate, it is aimed at restricting campus access to vaccinated persons, while at the same time considering applications for exemption based on medical and religious grounds, natural immunity objections, other legally acceptable exemptions, or those participating in clinical trials approved by the South African Health Products Regulatory Authority (SAHPRA). Employee and Student Vaccination Exemption Committees will evaluate applications for exemption. These committees will operate independently, and will include medical, religious, legal and psychology experts.

Vaccinated persons will be required to upload their vaccination certificates on an electronic platform to obtain access to campus. Staff, ad hoc contract workers, and students who are not vaccinated, who do not have an approved exemption or deferral, and who do not have a SARS COVID-19 PCR negative result that is not older than a week, will not be allowed access to the campuses or facilities. Only vaccinated students will be allowed to access on-campus accommodation. 

Students who are not vaccinated by 14 February 2022, will not be prevented from registering for the academic year, but can only access the campus if vaccinated or granted an exemption. 

Consultation process and thorough risk assessment

“The development of the policy was consulted widely with relevant internal stakeholders, among others, the university’s Senate, supporting it with an overwhelming 84%. The university also followed due process by referring the proposed policy to all its governance structures for consultation – including obtaining opinions from reputable legal firms in the country,” said Prof Petersen. 

According to Prof Petersen, the UFS has conducted a thorough risk assessment of the implementation of the policy, and a contingency plan is in place that will be implemented in the absence of full implementation of the policy. “We will consider following a flexible approach if we initially find that the rate of vaccinations is low. We will work tirelessly with government to accelerate the rate of vaccinations with the ultimate goal to obtain a high enough level of vaccinations to limit the transmission of the COVID-19 virus and create a safe work and study environment for our staff and students,” he said. 

VIEW the Roads to Return to Campus 2022 Infographic here



Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

Inaugural lecture: Prof Robert Bragg, Dept. of Microbial, Biochemical and Food Biotechnology
2006-05-17



Attending the inaugural lecture were in front from the left Prof Robert Bragg (lecturer at the Department of Microbial, Biochemical and Food Biotechnology) and Frederick Fourie (Rector and Vice-Chancellor).  At the back from the left were Prof James du Preez (Departmental Chairperson:  Department of Microbial, Biochemical and Food Biotechnology) and Prof Herman van Schalkwyk (Dean: Faculty of Natural and Agricultural Sciences). Photo: Stephen Collett
 

A summary of an inaugural lecture delivered by Prof Robert Bragg at the University of the Free State:

CONTROL OF INFECTIOUS AVIAN DISEASES – LESSONS FOR MAN?

Prof Robert R Bragg
Department of Microbial, Biochemical and Food Biotechnology
University of the Free State

“Many of the lessons learnt in disease control in poultry will have application on human medicine,” said Prof Robert Bragg, lecturer at the University of the Free State’s (UFS) Department of Microbial, Biochemical and Food Biotechnology during his inaugural lecture.

Prof Bragg said the development of vaccines remains the main stay of disease control in humans as well as in avian species.  Disease control can not rely on vaccination alone and other disease-control options must be examined.  

“With the increasing problems of antibiotic resistance, the use of disinfection and bio security are becoming more important,” he said.

“Avian influenza (AI) is an example of a disease which can spread from birds to humans.  Hopefully this virus will not develop human to human transmission,” said Prof Bragg.

According to Prof Bragg, South Africa is not on the migration route of water birds, which are the main transmitters of AI.  “This makes South Africa one of the countries less likely to get the disease,” he said.

If the AI virus does develop human to human transmission, it could make the 1918 flu pandemic pale into insignificance.  During the 1918 flu pandemic, the virus had a mortality rate of only 3%, yet more than 50 million people died.

Although the AI virus has not developed human-to-human transmission, all human cases have been related to direct contact with infected birds. The mortality rate in humans who have contracted this virus is 67%.

“Apart from the obvious fears for the human population, this virus is a very serious poultry pathogen and can cause 100% mortality in poultry populations.  Poultry meat and egg production is the staple protein source in most countries around the world. The virus is currently devastating the poultry industry world-wide,” said Prof Bragg.

Prof Bragg’s research activities on avian diseases started off with the investigation of diseases in poultry.  “The average life cycle of a broiler chicken is 42 days.  After this short time, they are slaughtered.  As a result of the short generation time in poultry, one can observe changes in microbial populations as a result of the use of vaccines, antibiotics and disinfectants,” said Prof Bragg.   

“Much of my research effort has been directed towards the control of infectious coryza in layers, which is caused by the bacterium Avibacterium paragallinarum.  This disease is a type of sinusitis in the layer chickens and can cause a drop in egg product of up to 40%,” said Prof Bragg.

The vaccines used around the world in an attempt to control this disease are all inactivated vaccines. One of the most important points is the selection of the correct strains of the bacterium to use in the vaccine.

Prof Bragg established that in South Africa, there are four different serovars of the bacterium and one of these, the serovar C-3 strain, was believed to be unique to Southern Africa. He also recently discovered this serovar for the first time in Israel, thus indicating that this serovar might have a wider distribution than originally believed.

Vaccines used in this country did not contain this serovar.  Prof Bragg established that the long term use of vaccines not containing the local South African strain resulted in a shift in the population distribution of the pathogen.

Prof Bragg’s research activities also include disease control in parrots and pigeons.   “One of the main research projects in my group is on the disease in parrots caused by the circovirus Beak and Feather Disease virus. This virus causes serious problems in the parrot breeding industry in this country. This virus is also threatening the highly endangered and endemic Cape Parrot,” said Prof Bragg.

Prof Bragg’s research group is currently working on the development of a DNA vaccine which will assist in the control of the disease, not only in the parrot breeding industry, but also to help the highly endangered Cape Parrot in its battle for survival.

“Not all of our research efforts are directed towards infectious coryza or the Beak and Feather Disease virus.  One of my Masters students is currently investigating the cell receptors involved in the binding of Newcastle Disease virus to cancerous cells and normal cells of humans. This work will also eventually lead to a possible treatment of cancer in humans and will assist with the development of a recombinant vaccine for Newcastle disease virus,” said Prof Bragg.

We are also currently investigating an “unknown” virus which causes disease problems in poultry in the Western Cape,” said Prof Bragg.
 
“Although disinfection has been extensively used in the poultry industry, it has only been done at the pre-placement stage. In other words, disinfectants are used before the birds are placed into the house. Once the birds are placed, all use of disinfectants stops,” said Prof Bragg.

“Disinfection and bio security can be seen as the ‘Cinderella’ of disease control in poultry.  This is also true for human medicine. One just has to look at the high numbers of people who die from hospital-acquired infections to realise that disinfection is not a concept which is really clear in human health care,” said Prof Bragg.

Much research has been done in the control of diseases through vaccination and through the use of antibiotics. “These pillars of disease control are, however, starting to crumble and more effort is needed on disinfection and bio security,” said Prof Bragg.

Prof Bragg has been working in close co-operation with a chemical manufacturing company in Stellenbosch to develop a unique disinfectant which his highly effective yet not toxic to the birds.

As a result of this unique product, he has developed the continual disinfection program for use in poultry. In this program the disinfectant is used throughout the production cycle of the birds. It is also used to ensure that there is excellent pre-placement disinfection.

“The program is extensively used for the control of infectious diseases in the parrot-breeding industry in South Africa and the product has been registered in 15 countries around the world with registration in the USA in the final process,” said Prof Bragg.

“Although the problem of plasmid mediated resistance to disinfectants is starting to rear its ugly head, this has allowed for the opening of a new research field which my group will hopefully exploit in the near future,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept